MILENA ADAMIAN, MD
Managing Partner, Azimuth Ventures/LSAN

Milena Adamian is founder and executive of the Life Sciences Angel Network, which is focused on early-stage investing and entrepreneurial activities in medical devices and healthcare information technology and on the education of entrepreneurs and investors. 

Dr. Adamian brings the unique perspective of a clinician and academic researcher with genuine passion for breakthrough technologies enriched by industry knowledge, Wall Street, and venture capital experience. 

She spent last 20 years on various side of the medical device development. Her career included professional appointments at Interventional Cardiology department of Lenox Hill Hospital (NYC) and Columbus Hospital (Milan, Italy), Medical Director at Boston Scientific Corporation (NYSE:BSC), Equity analyst (Medical Devices and Supplies) at Lehman Brothers and Managing Director, Life Sciences, Easton Capital. 

Milena is actively involved in a number of accelerators and angel groups across the US. Milena’s past and present Board involvements include Xoft (now NYSE: ICAD), Cardiovascular Systems (now NYSE: CSII), Forge Medical, Precise Light Surgical, Comprehend Systems, Biotrace, Owlet Baby Care, VitaPortal (Russia). Milena is an investor in Quartzy, ZappRX, Wellframe and a number of other healthcare technology companies.
She is also an author of a number of scientific peer-reviewed papers and a frequent speaker at professional conferences. 

Dr. Adamian is a member of the American College of Cardiology. 

She holds an MSc degree in Biostatistics and Clinical Research Methods from Mailman School of Public Health at Columbia University, and MD and PhD degrees in Clinical Cardiology from the Russian Academy of Medical Sciences. 

Go to top

RAJNI ANEJA, MD, MBA
Strategic Executive, Clinical Transformation Leader, Humana

KDr. Rajni Aneja MD, MBA, CPE currently serves as Strategic Executive, Clinical Transformation Leader at Humana. Most recently Dr. Aneja, served as Executive Vice President of Joslin Diabetes Center, now serving as strategic advisor to Joslin, she worked in all areas of Joslin to address Joslin’s numerous local, national, and global initiatives.  Further, she was actively involved with Joslin’s partners and collaborators to create and deliver cost-effective and impactful diabetes solutions within today’s healthcare economic environment.

Prior to joining Joslin, Dr. Aneja was Chief Medical Officer for WebMD Health Services and in the past has held roles as the National Medical Director for Disease Management, Quality, and Standards for OptumHealth, a UnitedHealth Group company. She has been extensively involved in industry efforts to address the fundamental drivers of utilization and the quality of healthcare service delivery. She is an active contributing member of the Care Continuum Alliance (formerly the Disease Management Association of America) as well as the American College of Physician Executives.

Dr. Aneja is a certified physician executive with specialty training in family practice. She earned her medical degree from Research Medical Center in Kansas City, Missouri, and her physician executive M.B.A. from the University of Massachusetts. She is a speaker faculty for Tufts MD/MBA program in addition to serving on advisory boards for many health services and solution delivery organizations, focusing on technology and patient engagement/care coordination initiatives.

Go to top

KRISTIN BAKER
Business Development, Collective Health

Kristin currently leads strategic partnerships in her role as Director of Business Development for Collective Health. Collective Health is a cloud-based employer self-insurance platform that empowers companies to take control of their healthcare benefits. Collective Health partners with health plans, providers and other third party services to bring a better overall health benefits experience to employers and employees.
Prior to Collective, Kristin held several roles at Castlight Health including Business Development, Financial Planning and Investor Relations. At Castlight, Kristin developed partnerships with health plans and PBMs for a number of years before moving roles to work on the company's IPO in March 2014. Before joining Castlight, she was with Goldman Sachs, & Co. in the Healthcare Investment Banking Division, working with clients across many areas of the healthcare ecosystem—biotech, medical device, life sciences, and HCIT—on M&A and financing transactions. 

Kristin received her B.A. from Middlebury College and MBA from Stanford Graduate School of Business. She lives in San Francisco, CA with her husband and son. 

Go to top

GEOFFREY CLAPP
CEO, GetBetter

Geoffrey Clapp is the Co-founder and CEO of Better, a Personal Health Assistant service that gives people the means to worry less when it comes to health care and instead focus on being well.

Previously, he spent more than twelve years disrupting the telemedicine market with Health Hero Network. During his tenure at Health Hero, Geoffrey served multiple roles, including COO and CTO. As CTO, Geoffrey designed and implemented award winning hardware and software products, including Business Week’s 2000 Product of The Year.  

During his time as COO, he guided the company through the “bubble” bursting in Silicon Valley, and built the organization into the largest telehealth vendor in the world with cornerstone customers such as the Department of Veterans Affairs and McKesson. After selling Health Hero Network to Robert Bosch, Geoffrey now serves as advisor to Rock Health and dozens of other Health Technology Startups.

Go to top

ADAM FEINSTEIN, CFA
Managing Director, Vesey Street Capital Partners

Adam has a unique background with a wealth of experience as both a senior
healthcare executive and a Wall Street veteran; with a deep understanding of the entire
healthcare services industry.
Adam was until recently the Senior Vice President of Corporate Development, Strategic
Planning and Office of the CEO at Laboratory Corporation of America Holdings
(LabCorp). Adam joined LabCorp in 2012. Adam’s oversaw Merger and Acquisitions, Corporate
Development, Strategic Partnerships and Corporate Strategy. He also managed all of
the company’s partnerships with large Hospital Systems. He greatly expanded
LabCorp’s M&A strategy and hospital development efforts. Finally, he created the
LabCorp Corporate Venture Fund, an internal investment vehicle that has successfully
enhanced the company’s corporate development strategy.
Adam was in the inaugural class of the Nashville Health Care Council Fellowship
Program in 2013. The Council Fellows initiative brings together top industry executives
to explore new solutions that meet the challenges facing the U.S. health care system in
years ahead. The annual initiative engages these key professionals to better implement
business strategies, create value, drive industry growth and effect change. The Council
Fellows is co-directed by Former U.S. Senate Majority Leader Bill Frist, M.D.
Prior to joining LabCorp, Adam was the Managing Director in Equity Research at
Barclays Capital, where he covered, as well as coordinated, the firm's Health Care
Facilities and Medical Supplies and Devices research teams. Adam was ranked #1 in
the Institutional Investor All America Research Survey in the Health Care Facilities
category, for a decade and was considered the best healthcare services analyst on Wall
Street.
Adam also served in a similar capacity at Lehman Brothers (until it was acquired by
Barclays Capital). Adam is a Chartered Financial Analyst. He is a member of the New
York Society of Security Analysts and the CFA Institute. Adam graduated from the
University of Maryland at College Park with a B.S. in Business Management in 1994. He
also serves on the University of Maryland Smith Business School Dean’s Advisory
Board, as well as the Advisory Board for NYU Medical Center.

Go to top

ALLAN FINE
Executive Vice President, Chief Strategy and Operations Officer,
New York Eye and Ear Infirmary of Mount Sinai

Allan Fine is Executive Vice President, Chief Strategy and Operations Officer for New York Eye and Ear Infirmary of Mount Sinai (NYEE), the oldest specialty hospital in the United States.  Mr. Fine is responsible for the operations of clinical and non-financial departments related to the strategic and operational goals of NYEE.  He oversees all strategy and network development activities for NYEE.  This includes developing a growth and expansion plan addressing such issues as physician outreach strategies, service line and programmatic growth, ambulatory surgery center development, joint ventures, NYEE/physician satellite offices, international programs, new program development, product and research commercialization activities, and branding strategy.
 
Prior to his current position, Mr. Fine has served as Managing Director at Healthios, Inc., a merchant banking boutique specializing in healthcare, Director in the Life Sciences and Healthcare practice at Navigant Consulting, Inc., Senior Manager in the health care consulting practice of Ernst & Young, a Vice President at Quorum Health Resources, Inc., and as Director of Marketing and Sales for Rush Contract Care, the PPO and Utilization Management program of Rush Presbyterian-St. Luke’s Medical Center.  He has published extensively and has been a frequent speaker at national and regional conferences.  He has a MBA in health care administration from Baruch College-Mt. Sinai School of Medicine, City University of New York and a BBA, cum laude from Temple University.

Go to top

ALAN GREENE, MD, FAAP
Private Physician and Medical Futurist

WGround-breaking practicing physician Alan Greene launched DrGreene.com in 1995, cited by the American Medical Association as “the pioneer physician Web site” on the Internet. His award-winning site has had over 86 million Unique Visitors comprised of parents, concerned family members, students, and healthcare professionals.

Dr. Greene has devoted himself to freely giving real answers to parents’ real questions. His answers combine cutting edge science, practical wisdom, warm empathy, and a deep respect for parents, children, and the environment. He is also an electrifying public speaker, and has personally touched many during his talks in North America, Europe, Asia, and the Middle East.
Dr. Greene is the children’s health expert on the Medical Advisory Board for the Dr. Oz Show, and he appears on the show frequently each season. He is the Pediatric Expert for The People’s Pharmacy (as heard on NPR) and Healing Quest (seen on PBS stations). He was the original Pediatric Expert for both Yahoo! and iVillage and was a regular columnist for Parenting Magazine for many years.
Dr. Greene is the Founding President of the Society for Participatory Medicine and has served as President of The Organic Center and two terms on the Board of Directors of Healthy Child Healthy World. He is a founding partner of the Collaborative on Health and the Environment. He serves on the Board of the Institute for Responsible Nutrition as the Chair of their Scientific Advisory Board.

In 2010 Dr. Greene founded the WhiteOut Movement to change how babies in the United States are fed. In 2012 he founded TICC TOCC – Transitioning Immediate Cord Clamping To Optimal Cord Clamping. He is also the founder of KidGlyphs, an iPhone app that provides a tool for young children to express themselves beyond their verbal skills.

Dr. Greene is a graduate of Princeton University and the University of California at San Francisco. In addition to his own private practice, he is the Chief Medical Officer for Scanadu, a cutting edge health and technology company dedicated to empowering consumers with medical tools and education.
. 
Dr. Greene is the author of Feeding Baby Green (Wiley, 2009), Raising Baby Green (Wiley, 2007), From First Kicks to First Steps (McGraw-Hill, 2004), The Parent’s Complete Guide to Ear Infections (People’s Medical Society, 1997), and a co-author of The A.D.A.M. Illustrated Family Health Guide (A.D.A.M., Inc., 2004). He is the medical expert for three additional books.

Dr. Greene also appears frequently on TV, radio, websites, and in newspapers and magazines around the world, including such venues as the TODAY Show, Good Morning America, Fox and Friends, The Dr. Oz Show, CNN, ABC, CBS, and NBC network news, NPR, The New York Times, The Wall Street Journal, USA Today, and Time Magazine.

Go to top

WENDY GOLDSTEIN

Wendy C. Goldstein is a member of the Cooley business department and is a partner in the firm's Health Care & Life Sciences Regulatory practice. She is resident in the New York office.  Ms. Goldstein concentrates in healthcare fraud and abuse and government health care program matters relevant to manufacturers, payors and other ancillary providers in the health care life sciences space.  She also represents those entities that invest in such concerns.

Ms. Goldstein speaks and writes extensively on issues relating to fraud and abuse, board governance, government program pricing, corporate compliance, government enforcement activity relevant to the life sciences and managed care industries and health care reform. She serves on the board of directors of several non-profit health care associations, and educational institutions.  She also is actively involved in pro bono activities relating to the pediatric oncology research and other health care education and access initiatives.

Go to top

MARK HADFIELD
CEO, HelloMD

Mark, a serial entrepreneur, is on a mission to dramatically expand access to global healthcare by creating a friction-free marketplace for cash-based treatment options. HelloMD (@ondellortc) is a marketplace of the best doctors, advisors, and treatment options from around the globe. HelloMD is connecting patients with the best care options, at a price they can afford, globally. HelloMD is located in San Francisco, CA.

Go to top

JODY HOLTZMAN
Senior Vice President, Thought Leader, AARP

Jody Holtzman has more than two decades of experience helping companies develop and implement competitive strategies and achieve their strategic market goals.  At AARP, he leads the Thought Leadership group, where his focus is to stimulate innovation in the market that benefits people over 50. This involves areas such as the future of technology and the 50+, technology design for all, and 50+ entrepreneurship. It also involves developing partnerships with non-traditional players for AARP, such as the venture capital community, and the consumer electronics and technology industries. Previously, Jody led AARP’s Research and Strategic Analysis group.

Before joining AARP, Jody was in senior leadership roles in several strategy consulting firms. He was a Director of Global Strategy and Planning, and led the Market Intelligence Network of PricewaterhouseCoopers. Before that, he was Vice President of Consulting for FutureBrand, where he helped clients develop and implement competitive brand strategies. He also produced the Report to the President on the Exxon Valdez Spill, and authored position papers for the US delegation to the Montreal Protocol to Protect the Ozone Layer. Early in his career, Jody worked with developing countries to design and implement foreign investment promotion programs and economic development strategies.

Jody is a frequent speaker on the opportunities and challenges presented by the demographic wave. He has led numerous workshops on competitive strategy and organizational performance, and his work has been published in the Journal of Business Strategy, Competitive Intelligence Magazine, The Competitive Intelligence Anthology, and Making Cents Out of Knowledge Management. He has a graduate degree in international political economy from the University of Chicago.

Go to top

DESMOND HUSSEY
VP, Marketing, Product and Innovation, United Healthcare

Desmond J. Hussey is the regional vice president of Marketing, Product and Innovation for UnitedHealthcare Northeast.

Mr. Hussey began his career in healthcare at Oxford Health Plans in 1994 as a group sales representative in the New York City office.  Since then, Mr. Hussey has held numerous posts in marketing and product management, at Oxford and at UnitedHealthcare, which acquired Oxford in 2004.  

In his current role, he oversees new products and portfolio management in 12 states plus the District of Columbia. He was responsible for implementing the product requirements of PPACA across all business segments, and is actively engaged in interpreting regulations, and developing effective product responses. Recent product launches include Choice Advanced, a tiered product in New England, focused network products in New York, New Jersey, Pennsylvania, and the Mid-Atlantic, and new funding responses for businesses. He has also launched Compass, UnitedHealthcare’s Healthcare Exchange product, in six states.

Mr. Hussey is responsible for all aspects of Marketing in the Northeast states, including B2B campaigns for employer groups, product marketing support, development of Consumer campaigns to support Exchange activity, and the use of digital and social media to build the brand.

Before joining Oxford, Hussey worked in advertising and sales promotion, developing branding programs with The Disney Channel and other family-oriented organizations. He earned his bachelor of arts in economics at Middlebury College in Vermont. He lives in Wilton, Connecticut with his wife and three boys.

Go to top

ALAN LONDON, MD
Vice President, Strategic Clinical Partnerships, Walgreens Co.

Alan London is the Vice President, Strategic Clinical Partnerships, Walgreen Co., providing strategic leadership in designing and building clinically integrated health system relationships for Walgreens. He also provides strategic direction and leadership for Healthcare Clinic’s service expansion, quality, clinical education and training, and collaborative physician practice agreement functions.  Prior to this position, he was Chief Medical Officer for Take Care Health Systems and helped lead the clinical service expansion, quality, clinical education/training and health system affiliations for the 400+ Retail Clinic division.

Dr. London is a family physician with more than three decades of experience in patient care delivery, healthcare strategy and business development.  He has worked within the managed care contracting and risk management fields, while also spending extensive time in the hospital and healthcare system setting, serving at the Cleveland Clinic for 12 years.  Most recently, Dr. London was the President of the London Group International, a firm providing innovative healthcare solutions for health systems, insurers, governments, physicians, and the investment community.  He is a co-founder of two healthcare companies, Clinically Home, LLC and MX.com.

Dr. London holds a number of professional appointments including membership on the Physician Advisory Council for WellPoint and served for seven years as Director on the Board of Advocate Physician Partners in Chicago.  He earned a Bachelor of Science degree from the University of Cincinnati and received his MD from the Medical College of Ohio.  He then completed a residency in family medicine from the University of California, Irvine.

Go to top

LISA MAKI
CEO, PokitDok

With her rich background in technology, Lisa and her co—founder & CTO, Ted Tanner, Jr., created PokitDok to allow customers to “cut to the chase” while searching for information on physicians, their treatments and services and the cash prices they charge. Before starting PokitDok, Lisa co—founded BeliefNetworks with Ted, which applied semantic intelligence and predictive analytics for the Department of Defense and other tech companies, and was later acquired by the health and employee benefits company, Benefitfocus (NASDAQ: BNFT, IPO 2013). Earlier in her career, while at Microsoft, she was the Director of Program Management for all consumer products, during Bill Gates's tenure. She earned her BA from Stanford University.

Go to top

JAMES MERLINO, MD
Chief Experience Officer, Cleveland Clinic

ames Merlino, MD, is the Chief Experience Officer of the Cleveland Clinic Health System, and is a practicing staff colorectal surgeon in the Digestive Disease Institute. He is also the founder and current president of the Association for Patient Experience.

As a member of the Clinic’s executive team, he leads initiatives to improve the patient experience across the Cleveland Clinic Health System. In addition to his work in patient experience, he also leads efforts to improve physician-patient communication, and referring physician relations.

Partnering with key members of the Clinic leadership team, he helps to improve communication with physicians and employees, and to drive employee engagement strategies. Along with the Clinic CEO, he is co-chairperson of the Cleveland Clinic Diversity Council, and also sits on the professional affairs committee. He is a recognized world leader in the emerging field of patient experience. Dr. Merlino’s wife, Amy, is a maternal-fetal medicine specialist at Cleveland Clinic.

Go to top

REENA PANDE, MD, MSc
Chief Medical Officer, AbilTo

Reena Pande is Chief Medical Officer at AbilTo, where she serves as a passionate voice for the critical need for innovative ways to truly help individuals achieve meaningful behavior change in order to improve medical outcomes. She also spearheads AbilTo’s data analytics and outcomes research endeavors.

In addition to her work at AbilTo, Dr. Pande continues to practice as a cardiologist at Brigham and Women’s Hospital in Boston, MA and is an Instructor at Harvard Medical School. She is the author of several peer-reviewed publications and other contributions to the medical literature. She earned her undergraduate degree in Biology from Harvard University, her MD degree from Harvard Medical School and a Masters degree in Epidemiology from the Harvard School of Public Health.

She completed her internship, residency training, and fellowship in Cardiovascular Disease and Vascular Medicine at Brigham and Women’s Hospital in Boston, MA.

Go to top

CHERYL PEGUS, MD, MPH

Cheryl Pegus, M.D., M.P.H is the Director, Division of General Internal Medicine and Clinical Innovation, Associate Chair, Clinical Innovation at NYU Langone Medical Center and Clinical Professor of Medicine at NYULMC. She is the President of Caluent, LLC, a private equity advisory company with a portfolio of public and startup companies under management, a Director of Glytec and the Lead Independent Director of Vision Sciences, Inc. (VSCI).  Dr. Pegus is also the President of the American Heart Association (AHA) Founder’s Affiliate.

Dr. Pegus has more than 20 years of clinical practice and industry experience. Previously she was the Chief Medical Officer for Walgreens. She served as the General Manager and Chief Medical Officer for SymCare Personalized Health Solutions, Inc., a J&J start-up company, which provides wireless care management solutions utilizing remote monitoring, now part of the $2.6 billion J&J Diabetes Franchise. Prior to joining SymCare in 2007, she was the Head of Clinical Products for Aetna’s Medical Products Business Unit. Former positions at Aetna include National Medical Director, Clinical Program Development/Design and Marketing for Aetna’s Member Advantage programs, and National Medical Director for Women’s Health. Early in her career, she served as the Medical Director for the Cardiovascular Risk Factors Group at Pfizer Pharmaceuticals in New York.

She is a member of the Dean’s Circle at Weill Cornell Medical College, sits on the editorial advisory board of Disease Management Advisor , was a Founding Board member of the National Business Group on Health’s  (NBGH) Obesity Taskforce and is a a past board member of the Care Continuum Allliance.  Dr. Pegus has chaired the Health Disparities Taskforce for the AHA, Founder’s Affiliate and recently chaired the first AHA Health Equity Summit.

Dr. Pegus is a board-certified physician with subspecialty training in cardiology. She received an M.P.H. from Columbia University School of Public Health, an M.D. from Cornell University Medical College, completed her internal medicine residency and cardiology fellowship at New York Hospital-Cornell and practiced internal medicine and cardiology. She has published many peer-reviewed studies and  presented at national and international conferences. Dr. Pegus recently published the healthy cookbook, Everyone Eats.

Go to top

SALLY POBLETE
CEO and Co-Founder, Wellthie

Sally has been a leader and innovator in the health care industry for 18 years.  She founded Wellthie in 2013 out of a deep passion for making health insurance more simple and approachable for consumers.  

She had a successful career leading product development at WellPoint, one of the nation’s largest health insurance companies.  An entrepreneur at heart, she also ran a long-term health care business and worked at several health care start-ups like HealthMarket and Medscape.  

Sally received her B.S. in Management, magna cum laude from New York University and received her MBA from the Wharton School at the University of Pennsylvania, specializing in Health Care Management.

  
Go to top

ALAN RUSSELL, PhD
Chief Innovation Officer, Allegheny Health Network

He holds appointments in ICES and in the Department of Biomedical Engineering and will be launching a Disruptive Health Technology initiative. Increasing the simplicity, affordability, and accessibility of healthcare through science and engineering will be the goal of the new program. Over the next six months, teams from CMU, Highmark, and West Penn Allegheny Health System will develop strategic science and engineering driven programs in multiple areas.

Shortly after arriving at CMU, Dr Russell launched a new journal in partnership with Mary Ann Liebert Publishing entitled Disruptive Science and Technology. In addition to his appointments at CMU, Dr. Russell is the executive director of the Pittsburgh Tissue Engineering Initiative, Inc and a senior advisor to Highmark Inc.

Dr. Russell was the founding director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, serving in that capacity from 2001-2011. He has founded three biotechnology companies; ICX Agentase (now owned by FLIR), NanoSembly LLC (now owned by LIG Biosciences), and O2Cyte LLC. Dr. Russell was also the founding president of the now 3,000+ member Tissue Engineering and Regenerative Medicine International Society. Dr. Russell served as chair of the College of Fellows for the American Institute for Medical and Biological Engineering for 2012 and is a current member of the FDA's Science Board.

For the last 20 years, the Russell laboratory has been discovering what can be achieved by exploiting the rich interface of chemistry, biology, and materials. His work has impacted fields as diverse as chemical and polymer synthesis to tissue engineering and homeland defense. Dr. Russell has pioneered how to make polymers from enzymes and how to incorporate enzymes into bulk polymers. In a series of discoveries, his laboratory has found how to meld the synthetic and biological worlds.

Go to top

JACOB SATTELMAIR
CEO and Co-Founder, Wellframe

Jacob’s work and research lie at the intersection of healthcare, technology, data analytics and consumer engagement.

He is a co-founder and CEO at Wellframe, a Boston-based health tech company that combines mobile devices and artificial intelligence to amplify therapeutic relationships in order optimally engage patients in personalized care plans.

Jacob was previously Product Manager at RunKeeper, a leading mobile/web health and fitness platform. Prior to that, he was the Director of Research and Strategy at Dossia, an employer driven health IT initiative.  He holds a doctorate in Epidemiology from the Harvard School of Public Health, where his research focused on lifestyle behaviors and cardiovascular health. He previously championed the importance of physical activity to the brain and learning at the nonprofit The Ratey Institute, lectured in the Department of Physical Activity and Health Science at UMass Boston, interned with the Global Strategy on Diet, Physical Activity and Health at the World Health Organization, completed a Masters in Physiology, with distinction, at the University of Oxford (Exeter College) and holds a BA in Neurobiology, magna cum laude, from Harvard University.

  
Go to top

MICHELLE SNYDER
Welltok/Interwest Partners

Michelle Snyder is recognized as a marketing and strategy leader in the digital health space. She now leads all corporate and product marketing, marketing communications and public relations activities.
Michelle was most recently an Executive-in-Residence at InterWest Partners, investing in digital health companies and serving as an advisor to InterWest portfolio companies. Prior to InterWest, Michelle was one of the early executives at Epocrates and worked for over a decade to build the company into one of the leading mobile healthcare technology companies and the most recognized technology brand among clinicians. Prior to Epocrates, Michelle worked as a health strategy consultant with The Wilkerson Group and in health policy formation and implementation with the Lewin Group and the Georgetown Center for Health Policy Studies.
Michelle earned her M.B.A. at the Kellogg School of Management at Northwestern University and her B.A. from Carleton College.

Go to top

LISA SUENNEN
Venture Valkyrie

Lisa Suennen is Managing Partner at Venture Valkyrie Consulting, which provides business advisory services to large and small companies, venture capital and private equity firms and non profit organizations in the healthcare field.
Previously Lisa spent 15 years with Psilos Group, a healthcare-focused venture capital firm where she was a co-founder and Partner.
Prior to Psilos, Lisa helped build Merit Behavioral Care (formerly American Biodyne, Inc), an $800mm behavioral healthcare company where she held various senior executive roles from its early start-up days through exit. Previously, Lisa held various positions in marketing and productmanagement in companies in the high technology field.

Lisa is currently and Board Member of digital health companies Beyond Lucid Technologies and Pokitdok; a Board Member of the Dignity Health Foundation, a member of the Qualcomm Life Advisory Board, and an Advisor to the California Health Care Foundation Innovation Fund and an Advisor to HealthXL.    Lisa also serves as an Advisor to innovation consulting firm Accelevate, Inc.  
Lisa also writes a widely read blog on healthcare and healthcare investing at www.venturevalkyrie.com.   She has recently published her first book: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology, coauthored with Dr. David Shaywitz.

Lisa holds an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley, where she now teaches graduate courses on healthcare venture capital and the changing healthcare economy at the Haas School of Business.  Lisa also sits on the UC Berkeley National Advisory Council of the Institute of Governmental Studies.  

Go to top

FRANK WILLIAMS
CEO, Evolent Health

Frank serves as Evolent Health's CEO and is responsible for all aspects of the strategic and operational management of the firm. He also serves as Vice Chairman of The Advisory Board, a best practices research and technology provider to the health care industry.
During Frank's tenure as Chairman and CEO, The Advisory Board completed an initial public offering and grew to $450M+ in annual revenues with over 2,000 employees and $1.8B+ in market capitalization. Also, The Advisory Board was ranked in the top 20 best run companies in North America by Forbes, as well as a best place to work by Modern Healthcare and Washingtonian Magazine. Prior to joining The Advisory Board Company, Frank served as President of MedAmerica OnCall, President of Vivra Orthopedics and as a Management Consultant for Bain & Co. He currently serves on the boards of Privia Health and Head-Royce School. A native Californian, Frank received a BA with High Honors in Political Economies of Industrial Societies from the University of California, Berkeley, and an MBA from Harvard Business School. 

Go to top